Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1730 (LINC01730) is a non-coding RNA gene classified as a long intergenic non-coding RNA (lincRNA), typically denoting an RNA transcript longer than 200 nucleotides that does not encode protein and is located in intergenic regions of the genome, meaning its sequence does not overlap coding genes[1][5]. LINC01730 is listed in gene databases such as NCBI Gene and Ensembl, but there is no published experimental literature as of 2025 detailing its biological function, tissue distribution, regulation, or association with human diseases. While some lincRNAs are increasingly recognized as regulatory molecules with roles in gene expression, cell signaling, and disease (especially cancer), no such evidence currently exists for LINC01730 specifically[1][5].
None. As there are no drugs targeting LINC01730, mechanisms of action cannot be described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1730 (LINC01730).